Paul Hartmann AG

Equities

PHH2

DE0007474041

Medical Equipment, Supplies & Distribution

Market Closed - Deutsche Boerse AG Other stock markets 01:28:03 2024-04-26 pm EDT			5-day change	1st Jan Change
208 ^EUR	-1.89%		+0.48%	+0.97%

Mar. 12	Paul Hartmann AG Reports Earnings Results for the Full Year Ended December 31, 2023	CI
2023	Paul Hartmann AG Reports Earnings Results for the Half Year Ended June 30, 2023	CI

Palero agreed to acquire Sanimed Group from Paul Hartmann AG (DB:PHH2).

March 12, 2020

Palero Capital GmbH agreed to acquire Sanimed Group from Paul Hartmann AG (DB:PHH2) on March 13, 2020. The transaction is expected to close by April 1, 2020. Hendrik Röhricht of Weil, Gotshal & Manges LLP, Frankfurt acted as legal advisor to Palero Capital GmbH.

Latest news about Paul Hartmann AG

Paul Hartmann AG Reports Earnings Results for the Full Year Ended December 31, 2023	Mar. 11	CI
Paul Hartmann AG Reports Earnings Results for the Half Year Ended June 30, 2023	23-08-11	CI
Paul Hartmann AG Reports Earnings Results for the Half Year Ended June 30, 2022	22-08-11	CI
Paul Hartmann AG Reports Earnings Results for the Full Year Ended December 31, 2021	22-03-22	CI
Paul Hartmann AG Reports Earnings Results for the Half Year Ended June 30, 2021	21-08-10	CI
Paul Hartmann Ag Reports Earnings Results for the Full Year Ended December 31, 2020	21-03-22	CI
Paul Hartmann AG (DB:PHH2) acquired web care LBJ GmbH from Hanse Ventures BSJ GmbH, PDV Inter-Media Venture GmbH, ALSTIN II GmbH, Holtzbrinck Digital GmbH, Aschendorff Medien Gmbh & Co. KG, RI Digital Ventures GmbH, KfW and Schlütersche Verlagsgesellschaft mbH & Co. KG.	21-01-04	CI
Palero Capital GmbH completed the acquisition of Sanimed Group from Paul Hartmann AG (DB:PHH2),	20-03-30	CI
Palero agreed to acquire Sanimed Group from Paul Hartmann AG (DB:PHH2).	20-03-12	CI
StealthGas Inc. acquired Gaschem Bremen, Gaschem Stade and Gaschem Hamburg from Paul Hartmann AG (DB:PHH2) for $75 million.	20-01-22	CI
Hartmann Group Reports Earnings Results for the First Half of 2019; Provides Earnings Guidance for the Year 2019	19-08-02	CI
Paul Hartmann AG (DB:PHH2) acquired Safran Coating from Safran SA.	19-08-01	CI
HARTMANN GROUP Announces Management Changes	18-10-10	CI
BW Group Limited completed the acquisition of BTS Tanker Partners LLC from The Blackstone Group L.P. (NYSE:BX), Paul Hartmann AG (DB:PHH2) and Tufton Oceanic Finance Group.	18-07-30	CI
BW Group Limited entered into a definitive agreement to acquire BTS Tanker Partners LLC from The Blackstone Group L.P. (NYSE:BX), Paul Hartmann AG (DB:PHH2) and Tufton Oceanic Finance Group.	18-07-08	CI
Paul Hartmann AG Announces Consolidated Earnings Results for the Year 2017; Provides Earnings Guidance for the Year 2018	18-03-12	CI
Paul Hartmann AG (DB:PHH2) completed the acquisition of Lindor Product Portfolio from The Procter & Gamble Company (NYSE:PG).	17-06-30	CI
Paul Hartmann AG (DB:PHH2) agreed to acquire Lindor Product Portfolio from The Procter & Gamble Company (NYSE:PG).	17-03-01	CI
Paul Hartmann AG Reports Consolidated Earnings Results for 2015	16-03-22	CI
Paul Hartmann AG Announces Earnings Results for the Year Ended December 31, 2014; Provides Earnings Guidance for 2015; Proposes Dividend for 2014	15-03-25	CI
Hartmann Group Opens Medical Innovation Center at Heidenheim, Southern Germany	14-07-15	CI
Paul Hartmann AG Reports Earnings Results for the First Quarter of 2014; Provides Earnings Guidance for the Year 2014	14-05-02	CI
Paul Hartmann AG Announces Consolidated Earnings Results for the Year Ended December 31, 2013; Provides Earnings Guidance for the Year 2014	14-03-26	CI
Paul Hartmann AG (DB:PHH2) acquired Bace Comércio Internacional Ltda.	14-01-11	CI
Paul Hartmann AG Reports Consolidated Earnings Results for the Year 2012; Proposes Dividend for the Year 2012	13-03-25	CI

Chart Paul Hartmann AG

Duration

Period

More charts

Company Profile

Paul Hartmann AG is a Germany-based holding company that is principally engaged in the field of medical and healthcare products. The Company operates through four segments, namely Wound Management, Incontinence Management, Infection Management and Other Group Activities. The Wound Management segment comprises wound dressings, as well as products for compression treatment, immobilization, First Aid and diagnostic devices. The Incontinence Management segment includes absorbent products worn close to the body for incontinence hygiene, such as under pads for patients as well as patient hygiene products and medical skin care. The Infection Management segment covers a range of custom procedure trays, surgical draping systems, surgical clothing, and surgical and examination gloves as well as the disinfection assortment. The Other Group Activities includes activities in cotton-wool products, feminine hygiene, baby care, medical consumer goods and pharmaceutical products, among others.

Sector

Medical Equipment, Supplies & Distribution

More about the company

Income Statement Evolution

More financial data

Sector Medical Supplies

	1st Jan change	Capi.
PAUL HARTMANN AG	+0.97%	789M
COLOPLAST A/S	+11.84%	27.79B
SHANDONG WEIGAO GROUP MEDICAL POLYMER COMPANY LIMITED	-32.98%	2.98B
WINNER MEDICAL CO., LTD.	-15.97%	2.52B
INTCO MEDICAL TECHNOLOGY CO., LTD.	+11.90%	2.34B
HARTALEGA HOLDINGS	-1.11%	1.91B
HARBIN FUERJIA TECHNOLOGY CO., LTD.	-13.37%	1.83B
TOP GLOVE CORPORATION BHD.	-7.78%	1.39B
NAKANISHI INC.	-0.38%	1.27B
KANGJI MEDICAL HOLDINGS LIMITED	+4.01%	1.13B

Medical Supplies